Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Harmony Biosciences Holdings

HRMY
Current price
31.25 USD +0.53 USD (+1.73%)
Last closed 30.48 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 1 785 271 424 USD
Yield for 12 month -48.69 %
Week
Month
Year
HRMY
21.11.2021 - 28.11.2021

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. It offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania. Address: 630 West Germantown Pike, Plymouth Meeting, PA, United States, 19462

Analytics

WallStreet Target Price

40.78 USD

P/E ratio

12.3401

Dividend Yield

Current Year

+437 855 000 USD

Last Year

+305 440 000 USD

Current Quarter

+160 268 000 USD

Last Quarter

+134 216 000 USD

Current Year

+354 374 000 USD

Last Year

+249 922 000 USD

Current Quarter

+127 972 000 USD

Last Quarter

+109 208 000 USD

Key Figures HRMY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 223 748 992 USD
Operating Margin TTM 40.25 %
PE Ratio 12.3401
Return On Assets TTM 17.54 %
PEG Ratio
Return On Equity TTM 36.54 %
Wall Street Target Price 40.78 USD
Revenue TTM 541 918 016 USD
Book Value 8.22 USD
Revenue Per Share TTM 9.07 USD
Dividend Share
Quarterly Revenue Growth YOY 36.7 %
Dividend Yield
Gross Profit TTM 354 374 000 USD
Earnings Share 2.47 USD
Diluted Eps TTM 2.47 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY -56.3 %
Profit Margin 27.82 %

Dividend Analytics HRMY

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History HRMY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation HRMY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 12.3401
Forward PE 10.9409
Enterprise Value Revenue 2.9784
Price Sales TTM 3.2944
Enterprise Value EBITDA 7.5416
Price Book MRQ 3.7139

Financials HRMY

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators HRMY

For 52 weeks

18.61 USD 62.09 USD
50 Day MA 26.95 USD
Shares Short Prior Month 5 333 930
200 Day MA 33.86 USD
Short Ratio 7.27
Shares Short 5 925 049
Short Percent 28.58 %